Invention Grant
US09587033B2 Therapeutic and diagnostic applications targeting TNK-1 有权
针对TNK-1的治疗和诊断应用

Therapeutic and diagnostic applications targeting TNK-1
Abstract:
Disclosed herein are novel antibodies specific to Tnk1 or variants thereof. Also disclosed are methods of using such antibodies. The methods include therapeutic methods against certain types of cancers or infections involving administration of novel antibodies or fragments thereof. Also, methods of using highly selective antibodies for detecting aberrant Tnk1 or functionally deficient Tnk1.
Public/Granted literature
Information query
Patent Agency Ranking
0/0